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Boys with unexplained West syndrome should be
examined for a mutation in the Aristaless related
homeobox gene, especially, when the family history is
positive for mental retardation and epilepsy.
X-linked West syndrome is very rare. We report on
two brothers with West syndrome and dystonia with
polyalanine expansion of the Aristaless related homeo-
box gene (ARX).
The index patient (Fig. 1a; III-2) was the second child
of non-consanguineous parents, born in 2001 at term,
after an uneventful pregnancy and delivery (birth weight
3659 g, 75th percentile; length 51 cm, 75th percentile;
head circumference 35 cm, 50th percentile). At the age
of 3 months he developed infantile spasms and a hyp-
sarrhythmic EEG pattern. He promptly responded to
vigabatrin therapy. At 5 months a generalised dystonia,
i.e. increased muscle tone with dystonic posturing of
limbs, was evident. At the age of 3 years, he is able to
walk a few steps with help and grasping objects is very
diﬃcult. He has no expressive speech.
The elder brother of the index patient (Fig. 1a; III-1)
was born in 1996 by caesarean section because of neo-
natal macrosomia (birth weight 4200 g, 90th percentile;
length 53 cm, 90th percentile; head circumference 38 cm,
>90th percentile). At the age of 3 months he showed
dystonic movements and marked truncal hypotonia.
One month later he developed infantile spasms and a
hypsarrhythmic EEG pattern. He did not respond to
vigabatrin, but to ACTH. At the age of 8 years he is
wheel-chair bound, not talking, grasping objects is not
possible.
In both children metabolic tests and neuroimaging
(MRI) were normal. Actually, both brothers suﬀer from
a severe dystonia, mental impairment and rare general-
ised tonic-clonic seizures (the older brother), treated
with valproic acid.
The family history was remarkable. In the maternal
uncle (Fig. 1a; II-3, now 37 years old), spastic tetraple-
gia, mental retardation and epilepsy have been present
since early infancy. In retrospect, the epilepsy syndrome
could not be classiﬁed. MRI was not performed in this
uncle, the mother or the grandmother.
From the pedigree and the clinical ﬁndings we sus-
pected a mutation in the ARX gene. Following informed
consent, a sequence analysis of the coding region and
ﬂanking intronic sequences of the ARX gene was per-
formed. The male proband (index patient; Fig. 1a; III-2)
as well as his brother and uncle were found to be
hemizygous for a 21 bp GCG repeat expansion in exon 2
of the ARX gene c.333_334ins(GCG)7, which expands
the ﬁrst of four alanine tracts from normally 16 to 23
alanine residues (Fig. 1b,c). Both the mother (Fig. 11;
II-2) and the maternal grandmother (Fig. 1a; I-2) were
identiﬁed as heterozygous mutation carriers using an
optimised ﬂuorescence-based PCR assay.
Mutations in the ARX gene have been found in a
broad spectrum of disorders including X-linked
infantile spasms (ISSX)/West syndrome, mental retar-
dation [2], ataxia and dystonia (Partington syndrome),
syndromic and non-syndromic forms of mental retar-
dation, myoclonic epilepsy and X-linked lissencephaly
with abnormal genitalia (XLAG) [5, 6,8]. The muta-
tion found in our Swiss family, which is not related to
previously reported families, has been described before
in boys with infantile spasms and normal MRI, severe
mental and motor retardation [7]. In addition to Par-
tington syndrome, dystonia was described in a few
unpublished Australian and Norwegian cases [6], but
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other ARX mutations can result in a similar pheno-
type [1,3]. Present observations suggest some genotype-
phenotype correlation: The more severe inactivating
mutations such as early truncation mutations or mis-
sense mutations in the evolutionary conserved domains
cause the more severe phenotype of XLAG.
To our knowledge this is the ﬁrst family presenting
with typical features of X-linked West syndrome plus
dystonia plus palsy resulting from expansion of the
ﬁrst of the four polyalanine tracts, which previously
had only been associated with pure West syndrome.
Critical re-evaluation of the known West syndrome
families with similar mutations might reveal whether
some of the aﬀected family members indeed also
present with those additional symptoms. With the
identiﬁcation of causal ARX mutations in aﬀected
families, the previously described allelic clinical entities
need to be reconsidered, as many of the families like
the one reported here present with an overlapping
phenotype.
In mice, ARX is expressed in a signiﬁcant proportion
of neurons in the cortex, the striatum, the ganglionic
eminences and also in the spinal cord. In adult mice,
ARX expression is restricted to regions known to be rich
in GABAergic neurons such as the amygdala and the
olfactory bulb [4]. This could explain the occurrence of
seizures in the majority of patients with an ARX
mutation due to mislocalisation or dysfunction of
GABAergic neurons. Anticonvulsant drugs increasing
the neuronal GABA level, for instance valproic acid,
vigabatrin, and tiagabine, might theoretically be eﬀec-
tive in these patients.
Based on our observation and the data published by
Strømme et al. [6,7] and Kato et al. [1], we conclude that
ARX mutations should be taken into consideration in
boys with otherwise unexplained West syndrome.
Fig. 1 a Family pedigree. Black
symbols refer to patients with a
hemizygous ARX mutation,
dotted circles to heterozygous
female carriers. b Schematic
drawing of the ARX gene
indicating the polyalanine
domain in exon 2 (in green).
c Sequencing in exon 2 of
patient III.1 showing the
nt333_334ins(GCG)7 with
expansion of the ﬁrst of four
alanine tracts from 16 to 23
alanine residues
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